Cardiovascular magnetic resonance imaging in experimental models

Open Cardiovascular Medicine Journal

Volumn 4, Issue SPEC. ISSUE 2, 2010, Pages 278-292

  Price, Anthony N ^a   Cheung, King K ^a,b   Cleary, Jon O ^a,b   Campbell, Adrienne E ^a,b   Riegler, Johannes ^a,b   Lythgoe, Mark F ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiac MRI; Cardiac phenotyping; Experimental models; Mouse; Rat

Indexed keywords

CONTRAST MEDIUM;

ANGIOGRAPHY; ATHEROSCLEROSIS; BLOOD VESSEL; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; CARDIAC GATED IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR SYSTEM EXAMINATION; CELL VIABILITY; CINEANGIOCARDIOGRAPHY; CONGENITAL HEART DISEASE; CONTRAST ENHANCEMENT; CORONARY ARTERY BLOOD FLOW; EX VIVO STUDY; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; HEART DEVELOPMENT; HEART DISEASE; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART VENTRICLE WALL MOTION; IMAGE ANALYSIS; MAGNETIC RESONANCE ANGIOGRAPHY; NON INVASIVE PROCEDURE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PULSE RATE; REVIEW; SCINTIGRAPHY; SYNDROME CHARGE;

EID: 84855504394     PISSN: None     EISSN: 18741924     Source Type: Journal    
DOI: 10.2174/1874192401004010278     Document Type: Review

References (140)

1. Poon M, Fuster V, Fayad Z. Cardiac magnetic resonance imaging:a "one-stop-shop" evaluation of myocardial dysfunction. Curr OpinCardiol 2002; 17: 663-70.
2. Boxerman JL, Mosher TJ, McVeigh ER, Atalar E, Lima JA, Bluemke DA. Advanced MR imaging techniques for evaluation ofthe heart and great vessels. Radiographics 1998; 18: 543-64.
3. Ruff J, Wiesmann F, Hiller KH, et al. Magnetic resonance microimagingfor noninvasive quantification of myocardial function andmass in the mouse. Magn Reson Med 1998; 40: 43-8.
4. Siri FM, Jelicks LA, Leinwand LA, Gardin JM. Gated magneticresonance imaging of normal and hypertrophied murine hearts. AmJ Physiol 1997; 272: H2394-402.
5. Vallee JP, Ivancevic MK, Nguyen D, Morel DR, Jaconi M. Currentstatus of cardiac MRI in small animals. MAGMA 2004; 17: 149-56.
6. Schepkin VD, Brey WW, Gor'kov PL, Grant SC. Initial in vivorodent sodium and proton MR imaging at 21.1 T. Magn Reson Imaging2009 [Epub ahead of print].
7. Gilson WD, Kraitchman DL. Cardiac magnetic resonance imagingin small rodents using clinical 1.5 T and 3.0 T scanners. Methods2007; 43: 35-45.
8. Cassidy PJ, Schneider JE, Grieve SM, Lygate C, Neubauer S, Clarke K. Assessment of motion gating strategies for mouse magneticresonance at high magnetic fields. J Magn Reson Imaging2004; 19: 229-37.
9. Sekihara K. Steady-state magnetizations in rapid NMR imagingusing small flip angles and short repetition intervals. IEEE TransMed Imaging 1987; 6: 157-64.
10. Geest RJ, Buller VG, Jansen E, et al. Comparison between manualand semiautomated analysis of left ventricular volume parametersfrom short-axis MR images. J Comput Assist Tomogr 1997; 21:756-65.
11. Heijman E, Aben JP, Penners C, et al. Evaluation of manual andautomatic segmentation of the mouse heart from CINE MR images. J Magn Reson Imaging 2008; 27: 86-93.
12. Furber A, Balzer P, Cavaro-Menard C, et al. Experimental validationof an automated edge-detection method for a simultaneous determinationof the endocardial and epicardial borders in short-axiscardiac MR images: application in normal volunteers. J MagnReson Imaging 1998; 8: 1006-14.
13. Young AA, Cowan BR, Thrupp SF, Hedley WJ, Dell'Italia LJ. Leftventricular mass and volume: fast calculation with guide-pointmodeling on MR images. Radiology 2000; 216: 597-602.
14. Heiberg E, Wigström L, Carlsson M, Bolger AF, Karlsson M. Timeresolved three-dimensional automated segmentation of the leftventricle. Proc IEEE Comp Cardiol 2005; 32: 599-602.
15. Slawson SE, Roman BB, Williams DS, Koretsky AP. Cardiac MRIof the normal and hypertrophied mouse heart. Mag Reson Med1998; 39: 980-7.
16. ten Hove M, Lygate CA, Fischer A, et al. Reduced inotropic reserveand increased susceptibility to cardiac ischemia/reperfusioninjury in phosphocreatine-deficient guanidinoacetate-N-methyltransferase-knockout mice. Circulation 2005; 111: 2477-85.
17. Alfakih K, Reid S, Jones T, Sivananthan M. Assessment of ventricularfunction and mass by cardiac magnetic resonance imaging. Eur Radiol 2004; 14: 1813-22.
18. Gutberlet M, Abdul-Khaliq H, Grothoff M, et al. Evaluationof left ventricular volumes in patients with congenital heartdisease and abnormal left ventricular geometry. Rofo 2003; 175:942-51.
19. Germain P, Roul G, Kastler B, Mossard JM, Bareiss P, Sacrez A. Inter-study variability in left ventricular mass measurement. Comparisonbetween M-mode echography and MRI. Eur Heart J 1992;13: 1011-9.
20. Streif JU, Herold V, Szimtenings M, et al. In vivo time-resolvedquantitative motion mapping of the murine myocardium with phasecontrast MRI. Magn Reson Med 2003; 49: 315-21.
21. Zerhouni EA, Parish DM, Rogers WJ, Yang A, Shapiro EP. Human heart: tagging with MR imaging--a method for noninvasiveassessment of myocardial motion. Radiology 1988; 169: 59-63.
22. Axel L, Dougherty L. MR imaging of motion with spatial modulationof magnetization. Radiology 1989; 171: 841-5.
23. Zhou R, Pickup S, Glickson JD, Scott CH, Ferrari VA. Assessmentof global and regional myocardial function in the mouse using cineand tagged MRI. Magn Reson Med 2003; 49: 760-4.
24. McVeigh E. Regional myocardial function. Cardiol Clin 1998; 16:189-206.
25. Atalar E, McVeigh ER. Optimization of tag thickness for measuringposition with magnetic resonance imaging. IEEE Trans MedImaging 1994; 13: 152-60.
26. Guttman MA, Prince JL, McVeigh ER. Tag and contour detectionin tagged MR images of the left ventricle. IEEE Trans Med Imaging1994; 13: 74-88.
27. Liu W, Chen JJ, Ji SB, et al. Harmonic phase MR tagging for directquantification of Lagrangian strain in rat hearts after myocardial infarction. Mag Reson Med 2004; 52: 1282-90.
28. Aletras AH, Ding S, Balaban RS, Wen H. DENSE: displacementencoding with stimulated echoes in cardiac functional MRI. J MagnReson 1999; 137: 247-52.
29. Osman NF, Sampath S, Atalar E, Prince JL. Imaging longitudinalcardiac strain on short-axis images using strain-encoded MRI. Magn Reson Med 2001; 46: 324-34.
30. Kraitchman DL, Sampath S, Castillo E, et al. Quantitative ischemiadetection during cardiac magnetic resonance stress testing by use ofFastHARP. Circulation 2003; 107: 2025-30.
31. Osman NF, Kerwin WS, McVeigh ER, Prince JL. Cardiac motiontracking using CINE harmonic phase (HARP) magnetic resonanceimaging. Mag Reson Med 1999; 42: 1048-60.
32. Yeon SB, Reichek N, Tallant BA, et al. Validation of in vivo myocardialstrain measurement by magnetic resonance tagging with sonomicrometry. J Am Coll Cardiol 2001; 38: 555-61.
33. Moore CC, McVeigh ER, Zerhouni EA. Noninvasive measurementof three-dimensional myocardial deformation with tagged magneticresonance imaging during graded local ischemia. J CardiovascMagn Reson 1999; 1: 207-22.
34. Henson RE, Song SK, Pastorek JS, Ackerman JJH, Lorenz CH. Left ventricular torsion is equal in mice and humans. Am J PhysiolHeart Circ Physiol 2000; 278: H1117-23.
35. Zhang H, Shea SM, Park V, et al. Accurate myocardial T1 measurements:toward quantification of myocardial blood flow with arterialspin labeling. Magn Reson Med 2005; 53: 1135-42.
36. Barkhausen J, Hunold P, Jochims M, Debatin JF. Imaging of myocardialperfusion with magnetic resonance. J Magn Reson Imaging2004; 19: 750-7.
37. Arai AE. Magnetic resonance first-pass myocardial perfusion imaging. Top Magn Reson Imaging 2000; 11: 383-98.
38. Pickup S, Zhou R, Glickson J. MRI estimation of the arterial inputfunction in mice. Acad Radiol 2003; 10: 963-8.
39. Belle V, Kahler E, Waller C, et al. In vivo quantitative mapping ofcardiac perfusion in rats using a noninvasive MR spin-labelingmethod. J Magn Reson Imaging 1998; 8: 1240-5.
40. Kober F, Iltis I, Izquierdo M, et al. High-resolution myocardialperfusion mapping in small animals in vivo by spin-labeling gradient-echo imaging. Magn Reson Med 2004; 51: 62-7.
41. Streif JU, Nahrendorf M, Hiller KH, et al. In vivo assessment ofabsolute perfusion and intracapillary blood volume in the murinemyocardium by spin labeling magnetic resonance imaging. MagnReson Med 2005; 53: 584-92.
42. Waller C, Kahler E, Hiller KH, et al. Myocardial perfusion andintracapillary blood volume in rats at rest and with coronary dilatation:MR imaging in vivo with use of a spin-labeling technique. Radiology 2000; 215: 189-97.
43. Waller C, Hiller KH, Voll S, Haase A, Ertl G, Bauer WR. Myocardialperfusion imaging using a non-contrast agent MR imagingtechnique. Int J Cardiovasc Imaging 2001; 17: 123-32.
44. Vandsburger MH, French BA, Helm PA, et al. Multi-parameter invivo cardiac magnetic resonance imaging demonstrates normal perfusionreserve despite severely attenuated beta-adrenergic functionalresponse in neuronal nitric oxide synthase knockout mice. Eur Heart J 2007; 28: 2792-8.
45. Iltis I, Kober F, Dalmasso C, Lan C, Cozzone PJ, Bernard M. Invivo assessment of myocardial blood flow in rat heart using magneticresonance imaging: effect of anesthesia. J Magn Reson Imaging2005; 22: 242-7.
46. Kober F, Iltis I, Cozzone PJ, Bernard M. Myocardial blood flowmapping in mice using high-resolution spin labeling magneticresonance imaging: influence of ketamine/xylazine and isofluraneanesthesia. Magn Reson Med 2005; 53: 601-6.
47. Atalay MK, Forder JR, Chacko VP, Kawamoto S, Zerhouni EA. Oxygenation in the rabbit myocardium: assessment with susceptibility-dependent MR imaging. Radiology 1993; 189: 759-64.
48. Bandettini PA, Wong EC, Jesmanowicz A, Hinks RS, Hyde JS. Spin-Echo and gradient-echo EPI of human brain activation usingBOLD contrast: a comparative study at 1.5 T. NMR Biomed 1994;7: 12-20.
49. Shea SM, Fieno DS, Schirf BE, et al. T2-prepared steady-state freeprecession blood oxygen level-dependent MR imaging of myocardialperfusion in a dog stenosis model. Radiology 2005; 236: 503-9.
50. Kaandorp TAM, Lamb HJ, van der Wall EE, de Roos A, Bax JJ. Cardiovascular MR to access myocardial viability in chronicischaemic LV dysfunction. Heart 2005; 91: 1359-65.
51. Wiesmann F, Ruff J, Engelhardt S, et al. Dobutamine-stressmagnetic resonance microimaging in mice: acute changes ofcardiac geometry and function in normal and failing murine hearts. Circ Res 2001; 88: 563-9.
52. Nahrendorf M, Wiesmann F, Hiller KH, et al. Serial cine-magneticresonance imaging of left ventricular remodeling after myocardialinfarction in rats. J Magn Reson Imaging 2001; 14: 547-55.
53. Kuijpers D, Ho KYJA, van Dijkman PRM, Vliegenthart R, Oudkerk M. Dobutamine cardiovascular magnetic resonance forthe detection of myocardial ischemia with the use of myocardialtagging. Circulation 2003; 107: 1592-7.
54. Kramer CM, Malkowski MJ, Mankad S, Theobald TM, Pakstis DL, Rogers WJ. Magnetic resonance tagging and echocardiographicresponse to dobutamine and functional improvement after reperfusedmyocardial infarction. Am Heart J 2002; 143: 1046-51.
55. Williams SP, Gerber HP, Giordano FJ, et al. Dobutamine stresscine-MRI of cardiac function in the hearts of adult cardiomyocytespecificVEGF knockout mice. J Magn Reson Imaging 2001; 14:374-82.
56. Wu KC, Lima JAC. Noninvasive Imaging of myocardial viability-Current techniques and future developments. Circ Res 2003; 93:1146-58.
57. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayedcontrast enhancement to irreversible injury, infarct age, and contractilefunction. Circulation 1999; 100: 1992-2002.
58. Mcnamara MT, Tscholakoff D, Revel D, et al. Differentiation ofreversible and irreversible myocardial injury by MR imaging withand without Gadolinium-DTPA. Radiology 1986; 158: 765-9.
59. Rehwald WG, Fieno DS, Chen EL, Kim RJ, Judd RM. Myocardialmagnetic resonance imaging contrast agent concentrations afterreversible and irreversible ischemic injury. Circulation 2002; 105:224-9.
60. Yang ZQ, Berr SS, Gilson WD, Toufektsian MC, French BA. Simultaneous evaluation of infarct size and cardiac function in intactmice by contrast-enhanced cardiac magnetic resonance imagingreveals contractile dysfunction in noninfarcted regions early aftermyocardial infarction. Circulation 2004; 109: 1161-7.
61. Price AN, Cheung KK, Lim SL, Hausenloy DJ, Yellon DM, Lythgoe MF. Late gadolinium enhanced MRI in small animalmodels of myocardial infarction. J Cardiovasc Magn Reson 2010;12: P98
62. Hu TCC, Pautler RG, MacGowan GA, Koretsky AP. ManganeseenhancedMRI of mouse heart during changes in inotropy. MagnReson Med 2001; 46: 884-90.
63. Reese T, Bochelen D, Sauter A, Beckmann N, Rudin M. Magneticresonance angiography of the rat cerebrovascular system withoutthe use of contrast agents. NMR Biomed 1999; 12: 189-96.
64. Beckmann N. High resolution magnetic resonance angiographynon-invasively reveals mouse strain differences in the cerebrovascularanatomy in vivo. Mag Reson Med 2000; 44: 252-8.
65. Beckmann N, Stirnimann R, Bochelen D. High-resolution magneticresonance angiography of the mouse brain: application to murinefocal cerebral ischemia models. J Magn Reson 1999; 140: 442-50.
66. Ruff J, Wiesmann F, Lanz T, Haase A. Magnetic resonanceimaging of coronary arteries and heart valves in a living mouse:techniques and preliminary results. J Magn Reson 2000; 146: 290-6.
67. Miraux S, Serres S, Thiaudiere E, Canioni P, Merle M, FranconiJM. Gadolinium-enhanced small-animal TOF magnetic resonanceangiography. MAGMA 2004; 17: 348-52.
68. Ohlstein EH, Romanic AM, Clark LV, et al. Application of in vivoand ex vivo magnetic resonance imaging for evaluation of tranilaston neointima formation following balloon angioplasty of the rat carotidartery. Cardiovasc Res 2000; 47: 759-68.
69. Chandra S, Clark LV, Coatney RW, Phan L, Sarkar SK, OhlsteinEH. Application of serial in vivo magnetic resonance imaging toevaluate the efficacy of endothelin receptor antagonist SB 217242in the rat carotid artery model of neointima formation. Circulation1998; 97: 2252-8.
70. Choudhury RP, Fuster V, Badimon JJ, Fisher EA, Fayad ZA. MRIand characterization of atherosclerotic plaque: emerging applicationsand molecular Imaging. Arterioscler Thromb Vasc Biol 2002;22: 1065-74.
71. Manka DR, Gilson W, Sarembock I, Ley K, Berr SS. Noninvasivein vivo magnetic resonance imaging of injury-induced neointimaformation in the carotid artery of the apolipoprotein-E null mouse. J Magn Reson Imaging 2000; 12: 790-4.
72. Hockings PD, Roberts T, Galloway GJ, et al. Repeated threedimensionalmagnetic resonance imaging of atherosclerosis developmentin innominate arteries of low-density lipoprotein receptorknockoutmice. Circulation 2002; 106: 1716-21.
73. Itskovich VV, Lieb M, Aguinaldo JGS, Samber DD, Ramirez F, Fayad ZA. Magnetic resonance microscopy quantifies the diseaseprogression in Marfan syndrome mice. J Magn Reson Imaging2003; 17: 435-9.
74. Itskovich VV, Choudhury RP, Aguinaldo JGS, et al. Characterizationof aortic root atherosclerosis in ApoE knockout mice: Highresolutionin vivo and ex vivo MRM with histological correlation. Mag Reson Med 2003; 49: 381-5.
75. McAteer MA, Sibson NR, von Zur MC, et al. In vivo magneticresonance imaging of acute brain inflammation using microparticlesof iron oxide. Nat Med 2007; 13: 1253-8.
76. Holmes AA, Scollan DF, Winslow RL. Direct histological validationof diffusion tensor MRI in formaldehyde-fixed myocardium. Mag Reson Med 2000; 44: 157-61.
77. Hsu EW, Muzikant AL, Matulevicius SA, Penland RC, HenriquezCS. Magnetic resonance myocardial fiber-orientation mapping withdirect histological correlation. Am J Physiol 1998; 43: H1627-34.
78. Scollan DF, Holmes A, Winslow R, Forder J. Histological validationof myocardial microstructure obtained from diffusion tensormagnetic resonance imaging. Am J Physiol 1998; 44: H2308-18.
79. Chen JJ, Song SK, Liu W, et al. Remodeling of cardiac fiber structureafter infarction in rats quantified with diffusion tensor MRI. Am J Physiol 2003; 285: H946-54.
80. Chen JJ, Liu W, Zhang HY, et al. Regional ventricular wall thickeningreflects changes in cardiac fiber and sheet structure duringcontraction: quantification with diffusion tensor MRI. Am JPhysiol 2005; 289: H1898-1907.
81. Kohler S, Hiller KH, Waller C, Bauer WR, Haase A, Jakob PM. Investigation of the microstructure of the isolated rat heart: A comparisonbetween T*2-and diffusion-weighted MRI. Magn ResonMed 2003; 50: 1144-50.
82. Jiang Y, Pandya K, Smithies O, Hsu EW. Three-dimensional diffusiontensor microscopy of fixed mouse hearts. Magn Reson Med2004; 52: 453-60.
83. Chacko VP, Aresta F, Chacko SM, Weiss RG. MRI/MRS assessmentof in vivo murine cardiac metabolism, morphology, and functionat physiological heart rates. Am J Physiol 2000; 279: H2218-24.
84. Naumova AV, Weiss RG, Chacko VP. Regulation of murine myocardialenergy metabolism during adrenergic stress studied by invivo P-31 NMR spectroscopy. Am J Physiol 2003; 285: H1976-79.
85. Jansen MA, Van Emous JG, Nederhoff MGJ, Van Echteld CJA. Assessment of myocardial viability by intracellular Na-23 magneticresonance Imaging. Circulation 2004; 110: 3457-64.
86. Lewandowski ED. Cardiac carbon 13 magnetic resonance spectroscopy:On the horizon or over the rainbow? J Nucl Cardiol 2002; 9:419-28.
87. Herrero P, Gropler RJ. Imaging of myocardial metabolism. J NuclCardiol 2005; 12: 345-58.
88. Verdouw PD, van den Doel MA, de Zeeuw S, Duncker DJ. Animalmodels in the study of myocardial ischaemia and ischaemic syndromes. Cardiovasc Res 1998; 39: 121-35.
89. Christian TF, O'Connor MK, Schwartz RS, Gibbons RJ, RitmanEL. Technetium-99m MIBI to assess coronary collateral flow duringacute myocardial infarction in two closed-chest animal models. J Nucl Med 1997; 38: 1840-6.
90. Itter G, Jung W, Juretschke R, Schoelkens BA, Linz W. A model ofchronic heart failure in spontaneous hypertensive rats (SHR). LabAnim 2004; 38: 138-48.
91. Waller C, Hiller KH, Kahler E, et al. Serial magnetic resonanceimaging of microvascular remodeling in the infarcted rat heart. Circulation 2001; 103: 1564-9.
92. Hu K, Gaudron P, Anders HJ, et al. Chronic effects of early startedangiotensin converting enzyme inhibition and angiotensin AT(1)-receptor subtype blockade in rats with myocardial infarction: roleof bradykinin. Cardiovasc Res 1998; 39: 401-12.
93. Arai T, Kofidis T, Bulte JWM, et al. Dual in vivo magnetic resonanceevaluation of magnetically labeled mouse embryonic stemcells and cardiac function at 1.5 T. Mag Reson Med 2006; 55: 203-9.
94. Jennings RB, Sommers HM, Smyth GA, Flack HA, Linn H. Myocardialnecrosis induced by temporary occlusion of a coronary arteryin the dog. Arch Pathol 1960; 70: 68-78.
95. Lusis AJ. Atherosclerosis. Nature 2000; 407: 233-41.
96. Narayanaswamy M, Wright KC, Kandarpa K. Animal models foratherosclerosis, restenosis, and endovascular graft research. J VasInterv Radiol 2000; 11: 5-17.
97. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneoushypercholesterolemia and arterial lesions in mice lacking apolipoproteinE. Science 1992; 258: 468-71.
98. Gutstein DE, Fuster V. Pathophysiology and clinical significanceof atherosclerotic plaque rupture. Cardiovasc Res 1999; 41: 323-33.
99. Cai JM, Hatsukami TS, Ferguson MS, et al. In vivo quantitativemeasurement of intact fibrous cap and lipid-rich necrotic core sizein atherosclerotic carotid plaque-Comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation 2005; 112: 3437-44.
100. Douglas SA, Louden C, Vickeryclark LM, et al. A role for endogenousendothelin-1 in neointimal formation after rat carotid-arteryballoon angioplasty. Protective effects of the novel nonpeptide endothelinreceptor antagonist Sb-209670. Circ Res 1994; 75: 190-7.
101. Gabeler EE, van Hillegersberg R, Statius van Eps RG, et al. Acomparison of balloon injury models of endovascular lesions in ratarteries. BMC Cardiovasc Disord 2002; 2: 16-27.
102. Summers RM, Hedlund LW, Cofer GP, Gottsman MB, Manibo JF, Johnson GA. MR microscopy of the rat carotid-artery after ballooninjury by using an implanted imaging coil. Mag Reson Med 1995;33: 785-9.
103. Yamamoto T, Ikuta K, Oi K, et al. In vivo MR detection of vascularendothelial injury using a new class of MRI contrast agent. Bioorg Med Chem Lett 2004; 14: 2787-90.
104. Gnecchi M, He H, Liang OD, et al. Paracrine action accounts formarked protection of ischemic heart by Akt-modified mesenchymalstem cells. Nat Med 2005; 11: 367-8.
105. Wisenberg G, Lekx K, Zabel P, et al. Cell tracking and therapyevaluation of bone marrow monocytes and stromal cells usingSPECT and CMR in a canine model of myocardial infarction. JCardiovasc Magn Reson 2009; 11: 11.
106. Carr CA, Stuckey DJ, Tatton L, et al. Bone marrow-derived stromalcells home to and remain in the infarcted rat heart but fail toimprove function: an in vivo cine-MRI study. Am J Physiol HeartCirc Physiol 2008; 295: H533-42.
107. Daniel JS, Carolyn AC, Enca M, et al. Iron particles for noninvasivemonitoring of bone marrow stromal cell engraftment into, andisolation of viable engrafted donor cells from, the heart. Stem Cells2006; 24: 1968-75.
108. Engelmann MG, Theiss HD, Hennig-Theiss C, et al. Autologousbone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardialinfarction undergoing late revascularization: final resultsfrom the G-CSF-STEMI (Granulocyte Colony-Stimulating FactorST-Segment Elevation Myocardial Infarction) Trial. J Am CollCardiol 2006; 48: 1712-21.
109. Kim YJ, Kuh YM, Choe KO, et al. In vivo magnetic resonanceimaging of injected mesenchymal stem cells in rat myocardial infarction;simultaneous cell tracking and left ventricular functionmeasurement. Int J Cardiovasc Imaging 2009; 25: 99-109.
110. Moelker AD, Baks T, van den Bos EJ, et al. Reduction in infarctsize, but no functional improvement after bone marrow cell administrationin a porcine model of reperfused myocardial infarction. Eur Heart J 2006; 27: 3057-64.
111. van Laake LW, Passier R, Doevendans PA, Mummery CL. Humanembryonic stem cell-derived cardiomyocytes and cardiac repair inrodents. Circ Res 2008; 102: 1008-10.
112. Forrester JS, White AJ, Matsushita S, Chakravarty T, Makkar RR. New paradigms of myocardial regeneration post-infarction: tissuepreservation, cell environment, and pluripotent cell sources. JACC:Cardiovasc Interv 2009; 2: 1-8.
113. Janssens S, Dubois C, Bogaert J, et al. Autologous bone marrowderivedstem-cell transfer in patients with ST-segment elevationmyocardial infarction: double-blind, randomised controlled trial. Lancet 2006; 367: 113-21.
114. Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologousbone-marrow cell transfer after myocardial infarction: the BOOSTrandomised controlled clinical trial. Lancet 2004; 364: 141-8.
115. Amsalem Y, Mardor Y, Feinberg MS, et al. Iron-oxide labeling andoutcome of transplanted mesenchymal stem cells in the infarctedmyocardium. Circulation 2007; 116: I38-45.
116. Chris Heyn JAR. In vivo magnetic resonance imaging of singlecells in mouse brain with optical validation. Magn Reson Med2006; 55: 23-9.
117. Rogers WJ, Meyer CH, Kramer CM. Technology insight: in vivocell tracking by use of MRI. Nat Clin Pract Cardiovasc Med 2006;3: 554-62.
118. Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, KoretskyAP. MRI detection of single particles for cellular imaging. Proc NatAcad Sci U S A 2004; 101: 10901-6.
119. Wood JC, Otto-Duessel M, Aguilar M, et al. Cardiac iron determinescardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.Circulation 2005; 112: 535-43.
120. Wilhelm C, Gazeau F. Universal cell labelling with anionic magneticnanoparticles. Biomaterials 2008; 29: 3161-74.
121. Neri M, Maderna C, Cavazzin C, et al. Efficient in vitro labeling ofhuman neural precursor cells with superparamagnetic iron oxideparticles: relevance for in vivo cell tracking. Stem Cells 2008; 26:505-16.
122. Farrell E, Wielopolski P, Pavljasevic P, et al. Effects of iron oxideincorporation for long term cell tracking on MSC differentiation invitro and in vivo. Biochem Biophys Res Commun 2008; 369: 1076-81.
123. Paigen K. One hundred years of mouse genetics: an intellectualhistory. I. The classical period (1902-1980). Genetics 2003; 163: 1-7.
124. Mouse Genome Sequencing Consortium. Chinwalla AT, Cook LL, Delehaunty KD, et al. Initial sequencing and comparative analysisof the mouse genome. Nature 2002; 420: 520-62.
125. The International Mouse Knockout Consortium. Collins FS, Rossant J, Wurst W. A Mouse for All Reasons. Cell 2007; 128:9-13.
126. Kaufman MH. The atlas of mouse development. London: AcademicPress; 1992.
127. Weninger WJ, Geyer SH, Mohun TJ, et al. High-resolution episcopicmicroscopy: a rapid technique for high detailed 3D analysisof gene activity in the context of tissue architecture and morphology. Anat Embryol 2006; 211: 213-21.
128. Weninger WJ, Mohun TJ. Phenotyping transgenic embryos: a rapid3-D screening method based on episcopic fluorescence imagecapturing. Nat Genet 2002; 30: 59-65.
129. Petiet AE, Kaufman MH, Goddeeris MM, Brandenburg J, ElmoreSA, Johnson GA. High-resolution magnetic resonance histology ofthe embryonic and neonatal mouse: A 4D atlas and morphologicdatabase. Proc Natl Acad Sci U S A 2008; 105: 12331-6.
130. Goddeeris MM, Rho S, Petiet A, et al. Intracardiac septation requireshedgehog-dependent cellular contributions from outside theheart. Development 2008; 135: 1887-95.
131. Smith BR, Johnson GA, Groman EV, Linney E. Magnetic resonancemicroscopy of mouse embryos. Proc Natl Acad Sci U S A1994; 91: 3530-3.
132. Jacobs RE, Ahrens ET, Dickinson ME, Laidlaw D. Towards amicroMRI atlas of mouse development. Comput Med ImagingGraph 1999; 23: 15-24.
133. Schneider JE, Bamforth SD, Grieve SM, Clarke K, Bhattacharya S, Neubauer S. High-resolution, high-throughput magnetic paragraphsign resonance imaging of mouse embryonic paragraph signanatomy using a fast gradient-echo sequence. MAGMA 2003; 16:43-51.
134. Cleary JO, Price AN, Thomas DL, et al. Cardiac phenotyping inex vivo murine embryos using microMRI. NMR Biomed 2009; 22:857-66.
135. Johnson GA, Cofer GP, Gewalt SL, Hedlund LW. MorphologicPhenotyping with MR microscopy: the visible mouse. Radiology2002; 222: 789-93.
136. Bosman EA, Penn AC, Ambrose JC, Kettleborough R, StempleDL, Steel KP. Multiple mutations in mouse Chd7 provide modelsfor CHARGE syndrome. Hum Mol Genet 2005; 14: 3463-76.
137. Chapon C, Franconi F, Roux J, Marescaux L, Le Jeune J, LemaireL. In utero time-course assessment of mouse embryo developmentusing high resolution magnetic resonance imaging. Anat Embryol2002; 206: 131-7.
138. Hogers B, Gross D, Lehmann V, et al. Magnetic resonance microscopyof mouse embryos in utero. Anat Rec 2000; 260: 373-7.
139. Nieman BJ, Szulc KU, Turnbull DH. Three-dimensional, in vivoMRI with self-gating and image coregistration in the mouse. MagnReson Med 2009; 61: 1148-57.
140. Deans AE, Wadghiri YZ, Berrios-Otero CA, Turnbull DH. Mnenhancement and respiratory gating for in utero MRI of the embryonicmouse central nervous system. Magn Reson Med 2008; 59:1320-8.